<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title21.html">
                                    Title 21
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/21CFR606.html">Part 606
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 606.160  Records.
                            </h3>
                            <p class="depth1"><em>(a)</em></p><p class="depth2"><em>(1)</em> Records shall be maintained concurrently with the performance  of each significant step in the collection, processing, compatibility  testing, storage and distribution of each unit of blood and blood  components so that all steps can be clearly traced. All records shall be  legible and indelible, and shall identify the person performing the  work, include dates of the various entries, show test results as well as  the interpretation of the results, show the expiration date assigned to  specific products, and be as detailed as necessary to provide a complete  history of the work performed.</p><p class="depth2"><em>(2)</em> Appropriate records shall be available from which to determine  lot numbers of supplies and reagents used for specific lots or units of  the final product.</p><p class="depth1"><em>(b)</em> Records shall be maintained that include, but are not limited  to, the following when applicable:</p><p class="depth2"><em>(1)</em> Donor records:</p><p class="depth3"><em>(i)</em> Donor selection, including medical interview and examination and  where applicable, informed consent.</p><p class="depth3"><em>(ii)</em> Permanent and temporary deferrals for health reasons including  reason(s) for deferral.</p><p class="depth3"><em>(iii)</em> Donor adverse reaction complaints and reports, including  results of all investigations and followup.</p><p class="depth3"><em>(iv)</em> Therapeutic bleedings, including signed requests from attending  physicians, the donor's disease and disposition of units.</p><p class="depth3"><em>(v)</em> Immunization, including informed consent, identification of the  antigen, dosage and route of administration.</p><p class="depth3"><em>(vi)</em> Blood collection, including identification of the phlebotomist.</p><p class="depth3"><em>(vii)</em> Records to relate the donor with the unit number of each  previous donation from that donor.</p><p class="depth3"><em>(viii)</em> Records concerning the following activities performed under  Sec. Sec. 610.46, 610.47, and 610.48 of this chapter: Quarantine;  consignee notification; testing; notification of a transfusion  recipient, the recipient's physician of record, or the recipient's legal  representative; and disposition.</p><p class="depth3"><em>(ix)</em> Records of notification of donors deferred or determined not to  be suitable for donation, including appropriate followup if the initial  attempt at notification fails, performed under Sec. 630.6 of this  chapter.</p><p class="depth3"><em>(x)</em> The donor's address provided at the time of donation where the  donor may be contacted within 8 weeks after donation.</p><p class="depth3"><em>(xi)</em> Records of notification of the referring physician of a  deferred autologous donor, including appropriate followup if the initial  notification attempt fails, performed under Sec. 630.6 of this chapter.</p><p class="depth2"><em>(2)</em> Processing records:</p><p class="depth3"><em>(i)</em> Blood processing, including results and interpretation of all  tests and retests.</p><p class="depth3"><em>(ii)</em> Component preparation, including all relevant dates and times.</p><p class="depth3"><em>(iii)</em> Separation and pooling of recovered plasma.</p><p class="depth3"><em>(iv)</em> Centrifugation and pooling of source plasma.</p><p class="depth3"><em>(v)</em> Labeling, including initials of the person(s) performing the  procedure.</p><p class="depth2"><em>(3)</em> Storage and distribution records:</p><p class="depth3"><em>(i)</em> Distribution and disposition, as appropriate, of blood and blood  products.</p><p class="depth3"><em>(ii)</em> Visual inspection of whole blood and red blood cells during  storage and immediately before distribution.</p><p class="depth3"><em>(iii)</em> Storage temperature, including initialed temperature recorder  charts.</p><p class="depth3"><em>(iv)</em> Reissue, including records of proper temperature maintenance.</p><p class="depth3"><em>(v)</em> Emergency release of blood, including signature of requesting  physician obtained before or after release.</p><p class="depth2"><em>(4)</em> Compatibility test records:</p><p class="depth3"><em>(i)</em> Results of all compatibility tests, including crossmatching,  testing of patient samples, antibody screening and identification.</p><p class="depth3"><em>(ii)</em> Results of confirmatory testing.</p><p class="depth2"><em>(5)</em> Quality control records:</p><p class="depth3"><em>(i)</em> Calibration and standardization of equipment.</p><p class="depth3"><em>(ii)</em> Performance checks of equipment and reagents.</p><p class="depth3"><em>(iii)</em> Periodic check on sterile technique.</p><p class="depth3"><em>(iv)</em> Periodic tests of capacity of shipping containers to maintain  proper temperature in transit.</p><p class="depth3"><em>(v)</em> Proficiency test results.</p><p class="depth2"><em>(6)</em> Transfusion reaction reports and complaints, including records  of investigations and followup.</p><p class="depth2"><em>(7)</em> General records:</p><p class="depth3"><em>(i)</em> Sterilization of supplies and reagents prepared within the  facility, including date, time interval, temperature and mode.</p><p class="depth3"><em>(ii)</em> Responsible personnel.</p><p class="depth3"><em>(iii)</em> Biological product deviations.</p><p class="depth3"><em>(iv)</em> Maintenance records for equipment and general physical plant.</p><p class="depth3"><em>(v)</em> Supplies and reagents, including name of manufacturer or  supplier, lot numbers, expiration date and date of receipt.</p><p class="depth3"><em>(vi)</em> Disposition of rejected supplies and reagents used in the  collection, processing and compatibility testing of blood and blood  components.</p><p class="depth1"><em>(c)</em> A donor number shall be assigned to each accepted donor, which  relates the unit of blood collected to that donor, to his medical  record, to any component or blood product from that donor's unit of  blood, and to all records describing the history and ultimate  disposition of these products.</p><p class="depth1"><em>(d)</em> Records shall be retained for such interval beyond the  expiration date for the blood or blood component as necessary to  facilitate the reporting of any unfavorable clinical reactions. You must  retain individual product records no less than 10 years after the  records of processing are completed or 6 months after the latest  expiration date for the individual product, whichever is the later date.  When there is no expiration date, records shall be retained  indefinitely.</p><p class="depth1"><em>(e)</em> A record shall be available from which unsuitable donors may be  identified so that products from such individuals will not be  distributed.  [40 FR 53532, Nov. 18, 1975, as amended at 61 FR 47422, Sept. 9, 1996;  64 FR 45371, Aug. 19, 1999; 65 FR 66635, Nov. 7, 2000; 66 FR 31176, June  11, 2001; 72 FR 48798, Aug. 24, 2007]</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
